MAPT and Alzheimer disease: To extend our analysis to a larger number of AD cases and additional brain regions from the first case studied by cryo-EM [14], we used immuno-EM to assess filament morphologies and the labelling of extracted filaments by repeat-specific anti-tau antibodies.